×
戻る Agenda
S39 : Innovative Thinking to Optimize Drug Development for Rare Diseases - Ideas for Efficacy Evaluation and Strategies for Utilizing RWD -
Session Chair(s)
Kazuo Nakamura, PhD
Representative Director, Chairman and CEO
CMIC HOLDINGS, Japan
Speaker(s)
Kiichiro Toyoizumi
Janssen Pharmaceutical K.K, Japan
Associate Director, Statistics & Decision Sciences Department
Lovisa Berggren
UCB S.A., Germany
Professor, Department of Neurology
Kazumasa Tanzawa
St. Marianna University School of Medicine, Japan
Yasuhiro Araki, PhD
Ministry of Health, Labour and Welfare (MHLW), Japan
Director, Office of Clinical Trial Promotion, Health Policy Bureau
Osamu Komiyama
Pfizer R&D Japan G.K., Japan
Senior Manager, Statistical Research & Data Science